XML 34 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Investments in and Advances to Joint Ventures
9 Months Ended
Sep. 30, 2021
Equity Method Investments And Joint Ventures [Abstract]  
Investments in and Advances to Joint Ventures

14.

Investments in and Advances to Joint Ventures

The Company participates in joint ventures to bid, negotiate and complete specific projects. The Company is required to consolidate these joint ventures if it holds the majority voting interest or if the Company meets the criteria under the consolidation model, as described below.

The Company performs an analysis to determine whether its variable interests give the Company a controlling financial interest in a Variable Interest Entity (“VIE”) for which the Company is the primary beneficiary and should,

therefore, be consolidated. Such analysis requires the Company to assess whether it has the power to direct the activities of the VIE and the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE.

The Company analyzed all of its joint ventures and classified them into two groups: (1) joint ventures that must be consolidated because they are either not VIEs and the Company holds the majority voting interest, or because they are VIEs and the Company is the primary beneficiary; and (2) joint ventures that do not need to be consolidated because they are either not VIEs and the Company holds a minority voting interest, or because they are VIEs and the Company is not the primary beneficiary.

Many of the Company’s joint venture agreements provide for capital calls to fund operations, as necessary; however, such funding is infrequent and is not anticipated to be material.

Letters of credit outstanding described in “Note 10 – Debt and Credit Facilities” that relate to project ventures are $75.0 million and $59.3 million at September 30, 2021 and December 31, 2020, respectively.

In the table below, aggregated financial information relating to the Company’s joint ventures is provided because their nature, risk and reward characteristics are similar. None of the Company’s current joint ventures that meet the characteristics of a VIE are individually significant to the consolidated financial statements.

Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements (in thousands):

 

 

 

September 30, 2021

 

 

December 31, 2020

 

Current assets

 

$

253,105

 

 

$

292,407

 

Noncurrent assets

 

 

1,856

 

 

 

2,990

 

Total assets

 

 

254,961

 

 

 

295,397

 

Current liabilities

 

 

194,543

 

 

 

201,270

 

Total liabilities

 

 

194,543

 

 

 

201,270

 

Total joint venture equity

 

$

60,418

 

 

$

94,127

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2021

 

 

September 30, 2020

 

 

September 30, 2021

 

 

September 30, 2020

 

Revenue

 

$

101,816

 

 

$

117,344

 

 

$

296,685

 

 

$

335,511

 

Costs

 

 

86,726

 

 

 

105,223

 

 

 

260,129

 

 

 

304,308

 

Net income

 

$

15,090

 

 

$

12,121

 

 

$

36,556

 

 

$

31,203

 

Net income attributable to noncontrolling interests

 

$

7,411

 

 

$

5,862

 

 

$

17,711

 

 

$

15,086

 

 

The assets of the consolidated joint ventures are restricted for use only by the particular joint venture and are not available for the Company’s general operations.

Unconsolidated Joint Ventures

The Company accounts for its unconsolidated joint ventures using the equity method of accounting. Under this method, the Company recognizes its proportionate share of the net earnings of these joint ventures as “Equity in earnings (loss) of unconsolidated joint ventures” in the consolidated statements of income. The Company’s maximum exposure to loss as a result of its investments in unconsolidated joint ventures is typically limited to the aggregate of the carrying value of the investment and future funding commitments.

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements (in thousands):

 

 

 

September 30, 2021

 

 

December 31, 2020

 

Current assets

 

$

1,103,345

 

 

$

774,646

 

Noncurrent assets

 

 

554,366

 

 

 

585,802

 

Total assets

 

 

1,657,711

 

 

 

1,360,448

 

Current liabilities

 

 

789,072

 

 

 

703,287

 

Noncurrent liabilities

 

 

562,523

 

 

 

517,697

 

Total liabilities

 

 

1,351,595

 

 

 

1,220,984

 

Total joint venture equity

 

$

306,116

 

 

$

139,464

 

Investments in and advances to unconsolidated joint ventures

 

$

102,677

 

 

$

68,975

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2021

 

 

September 30, 2020

 

 

September 30, 2021

 

 

September 30, 2020

 

Revenue

 

$

728,461

 

 

$

594,640

 

 

$

1,701,262

 

 

$

1,286,087

 

Costs

 

 

697,493

 

 

 

551,624

 

 

 

1,604,538

 

 

 

1,202,315

 

Net income

 

$

30,968

 

 

$

43,016

 

 

$

96,724

 

 

$

83,772

 

Equity in earnings of unconsolidated joint ventures

 

$

9,570

 

 

$

16,741

 

 

$

26,528

 

 

$

26,624

 

 

The Company had net contributions to its unconsolidated joint ventures for the three months ended September 30, 2021, of $7.3 million and received net distributions from its unconsolidated joint ventures for the three months ended September 30, 2020, of $11.2 million. The Company had net contributions to its unconsolidated joint ventures for the nine months ended September 30, 2021 of $0.5 million and received net distributions from its unconsolidated joint ventures for the nine months ended September 30, 2020 of $23.2 million.

 

For the three and nine months ended September 30, 2021, the Company recorded write-downs of $5.5 million and $10.6 million, respectively, on an unconsolidated joint venture in the Critical Infrastructure segment as a result of changes in estimates made by the managing partner. The write-downs decreased operating and net income by $5.5 million and $4.1 million, respectively for the three months ended September 2021. Operating and net income were decreased by $10.6 million and $7.9 million, respectively, for the nine months ended September 30, 2021. The write-downs decreased diluted earnings per share by $0.04 and $0.07 for the three and nine months ended September 30, 2021.